Cypress Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,723
Closed -$323K 184
2017
Q1
$323K Buy
2,723
+4
+0.1% +$453 0.15% 134
2016
Q4
$272K Sell
2,719
-523
-16% -$56.1K 0.12% 149
2016
Q3
$409K Buy
3,242
+69
+2% +$8.53K 0.18% 111
2016
Q2
$371K Buy
3,173
+11
+0.3% +$1.25K 0.18% 111
2016
Q1
$327K Hold
3,162
0.15% 123
2015
Q4
$315K Hold
3,162
0.16% 118
2015
Q3
$288K Buy
+3,162
New +$317K 0.16% 132

Other funds holding ZBH

Cypress Wealth Advisors's ZBH Position: Q2 2017 in Review

Cypress Wealth Advisors sold out of Zimmer Biomet (ZBH) in Q2 2017, closing a stake of 2,723 shares — an estimated $323K sold.

Cypress Wealth Advisors first reported a position in ZBH in Q3 2015 and held it in 7 quarters. The position peaked at $409K in Q3 2016. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

  • Cypress Wealth Advisors reported no remaining Zimmer Biomet position as of Q2 2017 after selling out during the quarter.
  • Cypress Wealth Advisors sold 2,723 Zimmer Biomet shares in Q2 2017, an estimated $323K.
  • Cypress Wealth Advisors first reported a position in Zimmer Biomet in Q3 2015 and held it in 7 quarters.
  • Cypress Wealth Advisors's Zimmer Biomet position peaked at $409K in Q3 2016.
  • 819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on Cypress Wealth Advisors's 13F filing for Q2 2017, filed 16 Aug 2017.